| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.42B | +31.1% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | +33.7% |
| Gross margin | 16.6% | Net margin 2.2% |
| Revenue Q/Q | +7.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.35B | 83.4% |
| R&D | ¥0.01B | 3.0% |
| SG&A | ¥0.03B | 6.8% |
| Tax & other | ¥-0.00B | -0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材 ・ 雅本化学 ・ 隆华科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies